Immune Response after Vaccination against SARS-COV-2 in Patients with Chronic Diseases
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "COVID-19 Vaccines and Vaccination".
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 28524
Special Issue Editor
2. Rappaport Faculty of Medicine, Technion Israel, Haifa 32000, Israel
Interests: immune response to COVID-19 vaccine in patients with End Stage Kidney Disease; hemodialysis; acute kidney injury
Special Issue Information
Dear Colleagues,
The enormous toll of the SARS-CoV-2 pandemic on human lives, and its effects on morbidity, mortality and global economic disruption are not yet over. Vaccination was and still is the cornerstone and most effective measure in the global effort to end the pandemic. Patient groups with certain pre-existing medical conditions may have higher risks for adverse outcomes of SARS-CoV-2. These same patient groups may also have diminished response to SARS-CoV-2 vaccination. These groups were not included in the pivotal clinical trials of the vaccines, and for them, more information is being acquired from smaller-scale clinical trials. The management of COVID-19 in these populations may require specific adjustments of vaccination and other therapies.
This Special Issue aims to update the current knowledge and future directions of SARS-CoV-2 vaccination and management in patients with chronic medical conditions (patients with solid/hematological malignancies, those who have received organ transplants, patients on dialysis, those receiving immunosuppressive medications, elderly individuals, individuals with morbid obesity, and possibly other patient groups)
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Immune response to SARS-CoV-2 vaccines in patients with chronic diseases.
- Vaccination strategy and vaccine classes (additional and booster vaccine shots, combination of vaccine classes).
- Efficacy of vaccination in patients with chronic medical conditions: laboratory and/or clinical evaluation.
- SARS-CoV-2 management of the immunocompromised beyond vaccination.
- Other related topics.
Dr. Noa Berar Yanay
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19 vaccination response
- COVID-19 vaccination efficacy
- chronic diseases
- immunosuppressed patients
- vaccination strategy
- COVID-19 treatment
- COVID-19 prevention
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.